Wellnex - Trading Update (ASX:WNX)
Key Points
- $2.2M net sales for May with a gross margin of 40% (circa $880k)
- Gross margins are over 26% higher for the Jan - May period of 2024 versus the same period for 2023, with gross profit increasing from $2M to $3.3M in that period
- IP Licensing for the same period was $1.5M with a gross margin of 20.5%, compared to $3.3M for the same period last year with only a 5% gross margin
- New 'Wakey Wakey' products due for delivery in July, coinciding with the launch of Wellnex's new medicinal cannabis product 'Wellness Life' also in July
- The 'Wakey Wakey' products will be available through grocery stores + pharmacy retailers & wholesalers
- As outlined in the charts, revenue from Jan-May dropped from $13.1M to $8.4M for the same Jan-May period last year, however gross margins grew 65% from $2M to $3.3M
- The July launch of its medicinal cannabis product available through Chemist Warehouse & other pharmacies / dispensaries in conjunction with InstantConsult (over 125,000 consultations a year) entering a $500M+/year (and growing) market in Australia alone
- Chemist Warehouse retain a 10% holding in this JV, and have over 550 stores across Australia to distribute these products through
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 11 Jun
Wellnex - Trading Update (ASX:WNX)Key Points- $2.2M net sales...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online